New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Integra LifeSciences Holdings Corporation
IART
Shape
US Flag

NASDAQ

2B

Medical - Devices

Next Earning date - 05 May 2025

2B

Medical - Devices

Next Earning date - 05 May 2025

22.49USD

Shape-0.22 ( -0.97%)
moonAfter-hours 22.72$arrow-right-up0.05 (0.22%)
Market Closed (as of Mar 21, 20:00 EDT)
favorite-chart

Relative Strenght

25
favorite-chart

Volume Buzz

56%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

37%

Quote Panel

Shape
Updated March 24, 2025
1W 0.09 % 1M -8.41 % 3M -0.26 % 1Y -32.22 %

Key Metrics

Shape
  • Market Cap

    1.75B


  • Shares Outstanding

    77.22M


  • Share in Float

    66.12M


  • Dividende

    0


  • Earning Date

    05 May 2025


  • Price Target

    22.64


  • Average Volume

    659415


  • Beta

    1.231


  • Range

    16.81-35.49


  • Industry

    Medical - Devices


  • Website

    https://www.integralife.com


  • Sector

    Healthcare


Fundamentals

Shape

8.84x

P/E Ratio

1.09x

P/S Ratio

1.13x

P/B Ratio

1.3

Debt/Equity

-0.4%

Net Margin

$-0.1

EPS

How IART compares to sector?

P/E Ratio

Relative Strength

Shape

IART

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$2B

Shape279%

2025-Revenue

$2.46

Shape884%

2025-EPS

$330M

Shape317%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Sell

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Citigroup

downgrade

Previous: Neutral

2024-07-30

Now: Sell

BTIG

downgrade

Previous: Sell

2024-07-29

Now: Negative

BTIG

downgrade

Previous: Not converted

2024-07-29

Now: Sell

Oppenheimer

downgrade

Previous: Not converted

2024-05-07

Now: Perform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

0.74
vs 0.74

Q2.23

arrow
arrow

-13%

0.71
vs 0.82

Q3.23

arrow
arrow

-12%

0.76
vs 0.86

Q4.23

arrow
arrow

-5%

0.89
vs 0.94

Q1.24

arrow
arrow

-26%

0.55
vs 0.74

Q2.24

arrow
arrow

-11%

0.63
vs 0.71

Q3.24

arrow
arrow

-46%

0.41
vs 0.76

Q4.24

arrow
arrow

+9%

0.97
vs 0.89

Q1.25

arrow
arrow

-22%

0.43
vs 0.55

Q2.25

arrow
arrow

-9%

0.57
vs 0.63

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

+1%

380.8M  vs 376.6M

Q2.23

arrow
arrow

-4%

381.3M  vs 397.8M

Q3.23

arrow
arrow

-1%

382.4M  vs 385.2M

Q4.23

arrow
arrow

0%

397M  vs 398M

Q1.24

arrow
arrow

-3%

368.9M  vs 380.8M

Q2.24

arrow
arrow

+10%

418.2M  vs 381.3M

Q3.24

arrow
arrow

0%

380.8M  vs 382.4M

Q4.24

arrow
arrow

+11%

442.6M  vs 397M

Q1.25

arrow
arrow

+3%

381.2M  vs 368.9M

Q2.25

arrow
arrow

0%

417.1M  vs 418.2M

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

+1%

0.01
vs 0.03

Q2.23

arrow
arrow

+0%

0
vs 0.01

Q3.23

arrow
arrow

+1%

0.01
vs 0

Q4.23

arrow
arrow

+1%

0.01
vs 0.01

Q1.24

arrow
arrow

0%

-0.00
vs 0.01

Q2.24

arrow
arrow

-1%

-0.01
vs -0.00

Q3.24

arrow
arrow

-1%

-0.01
vs -0.01

Q4.24

arrow
arrow

+1%

0.01
vs -0.01

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

280

280
vs 283

-1%

Q2.23

arrow
arrow

286

286
vs 280

2%

Q3.23

arrow
arrow

262

262
vs 286

-8%

Q4.23

arrow
arrow

285

285
vs 262

9%

Q1.24

arrow
arrow

282

282
vs 285

-1%

Q2.24

arrow
arrow

242

242
vs 282

-14%

Q3.24

arrow
arrow

226

226
vs 242

-7%

Q4.24

arrow
arrow

221

221
vs 226

-2%

Earnings Growth

Latest News